相关实验视频
Updated: May 9, 2025
09:40
Detection of True IgE-expressing Mouse B Lineage Cells
Published on: December 1, 2014
10.9K
对IgE受体相互作用和破坏性抑制的结构和功能洞察
Alexander Eggel1,2, Theodore S Jardetzky3
1Department for BioMedical Research, University of Bern, Bern, Switzerland.
Immunological reviews
|April 30, 2025
概括
针对免疫球蛋白E (IgE) 的新疗法利用其独特的结构灵活性来破坏过敏反应. 这些先进的生物药物通过向自由和结合IgE来提供更快,更广泛的过敏治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 结构生物学 结构生物学
- 过敏研究 研究过敏
背景情况:
- 免疫球蛋白E (IgE) 对于防御至关重要,但对过敏反应至关重要.
- 免疫细胞上的IgE与FcεRI和CD23受体相互作用,增强2型免疫.
- IgE的形状灵活性决定了受体的结合和功能.
研究的目的:
- 审查IgE及其受体的结构和机制见解如何为下一代抗IgE疗法提供信息.
- 要突出"破坏性"IgE抑制剂的发展,这些抑制剂可以拆卸IgE:FcεRI复合体.
- 讨论这些新生物药物对于更快,更有效的过敏治疗的潜力.
主要方法:
- 对IgE构造和受体相互作用的结构研究的分析.
- 审查现有的抗IgE生物药物 (例如,奥马利祖马布) 和它们的局限性.
- 检查新的"破坏性"IgE抑制剂及其作用机制.
主要成果:
- 对于有选择性的FcεRI或CD23结合,IgE采用不同的构造 (开放/关闭).
- 目前的抗IgE疗法主要是中和自由IgE,在向结合IgE方面存在局限性.
- 新的"破坏性"抑制剂积极分解IgE:FcεRI复合体,使其能够快速降低敏感性.
结论:
- 了解IgE形态动态是设计先进抗IgE疗法的关键.
- 下一代"破坏性"IgE抑制剂具有更快开始和更广泛有效性的潜力.
- 这些多功能生物药物代表了IgE向过敏治疗的新时代.
相关概念视频
01:10Antibody Structure
57.5K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
57.5K
01:29The Two-State Receptor Model
1.8K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.8K
01:25Antibody Structure and Classes
645
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
645
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
01:30Enzyme Inhibition
77.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.4K